Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Inversin (INVS) encodes a ciliary protein essential for renal development and has been implicated in infantile nephronophthisis. Biallelic truncating and splice variants such as c.1789C>T (p.Arg597Ter) cause early-onset nephronophthisis, but comprehensive screening of Senior-Loken syndrome cohorts has not identified causative INVS variants, yielding zero probands and no segregation data. This absence of genetic findings in SLSN panels indicates a lack of direct clinical evidence connecting INVS to retinal manifestations.
Functional analyses reveal that INVERSIN can bind RNA and localize to stress granules upon translational inhibition (PMID:32994509), and mechanistic studies demonstrate INVERSIN regulates cortical actin dynamics and spindle positioning during mitosis, impacting nephron morphogenesis (PMID:23515530). These experiments support a general ciliopathy role but do not confirm a retinal phenotype in SLSN. Additional genetic and phenotypic studies are required to elucidate any potential contribution of INVS to Senior-Loken syndrome.
Key Take-home: While INVS is established in nephronophthisis, current data provide limited support for its role in Senior-Loken syndrome; inclusion in genetic testing panels should be interpreted cautiously.
Gene–Disease AssociationLimitedNo biallelic INVS variants reported in Senior-Loken syndrome cohorts Genetic EvidenceLimitedZero reported SLSN probands with INVS variants; known pathogenic variants only cause infantile nephronophthisis ([PMID:31706999]) Functional EvidenceSupportingINVERSIN interacts with RNA and stress granules ([PMID:32994509]) and regulates cortical actin during mitosis ([PMID:23515530]), consistent with ciliopathy pathomechanisms |